Investigation of the protective effects of piceatannol on experimental subarachnoid hemorrhage in rats.

Our results demonstrated that PCN might be a potential therapeutic adjuvant agent for the treatment of early brain injury (EBI) following SAH. Further studies are required to clarify the underlying mechanisms and treatment options of SAH.